Related Experiment Video
Updated: Jun 15, 2025

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
Published on: November 10, 2023
Chitosan Nanoparticle-Based Drug Delivery Systems: Advances, Challenges, and Future Perspectives
Alina Stefanache1, Ionut Iulian Lungu1, Nicoleta Anton2
1Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universității Street, 700115 Iași, Romania.
Chitosan nanoparticles (CNPs) enhance drug delivery by improving encapsulation, stability, and absorption, especially for hydrophobic drugs. These biocompatible nanoparticles offer sustained release and reduced toxicity, boosting therapeutic effectiveness and patient compliance.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Pharmaceutical Sciences
Background:
- Chitosan nanoparticles (CNPs) are increasingly explored for drug delivery applications.
- Challenges in drug delivery include poor bioavailability, especially for hydrophobic drugs, and systemic toxicity.
- Developing effective and safe drug delivery systems is crucial for improving therapeutic outcomes.
Purpose of the Study:
- To evaluate the effectiveness and applications of chitosan nanoparticles (CNPs) in drug delivery systems.
- To assess the encapsulation efficiency, drug release profiles, and bioavailability enhancement of CNPs.
- To investigate the stability, toxicity, and biocompatibility of CNPs for potential therapeutic use.
Main Methods:
- Chitosan nanoparticles (CNPs) were synthesized and characterized for drug encapsulation.
- In vitro studies were conducted to assess drug release kinetics at different pH values.
- In vivo studies, including histological analysis, were performed to evaluate systemic toxicity and biocompatibility.
Main Results:
- CNPs demonstrated high encapsulation efficiency (up to 90%) for various therapeutic agents.
- Extended drug release patterns were observed, significantly enhancing bioavailability, particularly for hydrophobic compounds.
- pH-sensitive swelling and gelation of CNPs facilitated targeted drug release in the intestine, with a 50-70% increase at specific pH values.
- In vivo tests showed significantly reduced systemic toxicity and no adverse effects at therapeutic dosages.
- Histological studies confirmed the biocompatibility and non-toxicity of CNPs.
Conclusions:
- Chitosan nanoparticles (CNPs) show significant potential as effective drug delivery vehicles.
- CNPs improve drug encapsulation, stability, bioavailability, and enable sustained, targeted release.
- The biocompatibility and low toxicity of CNPs support their suitability for long-term therapeutic applications, enhancing patient compliance.
More Related Videos
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Factors Affecting Dissolution: Particle Size and Effective Surface Area

